Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
286 Chapter 23 · Emergencies in <strong>Acute</strong> Lymphoblastic Leukemia<br />
receive a total radiation dose of 3000 cGy, with 1000–<br />
1,500 cGy of it applied to the nerve sheath and the cranial<br />
base [80].<br />
23.10 Other Organ Involvement<br />
Leukemic cells may infiltrate virtually any organ system,<br />
especially in mature B-cell ALL (32%) and T-cell<br />
ALL, and usually do not cause significant morbidity.<br />
However, patients presenting with diffuse abdominal<br />
pain require immediate evaluation by the surgeon,<br />
due to high mortality rate (100%) from bowel perforation<br />
attributable to leukemic infiltrates [81]. Cases of<br />
splenic rupture form leukemic infiltrate and priapism<br />
due to leukostasis in corpora cavernosa and dorsal<br />
vein and sacral involvement in ALL have been described<br />
[82, 83].<br />
References<br />
1. O‘Regan S, Carson S, Chesney RW, Drummond KN (1977) Electrolyte<br />
and acid-base disturbances in the management of leukemia.<br />
Blood 49(3):345–353<br />
2. Ten Harkel AD, Kist-Van Holthe JE, Van Weel M, Van der Vorst MM<br />
(1998) Alkalinization and the tumor lysis syndrome. Med Pediatr<br />
Oncol 31(1):27–28<br />
3. Jones DP, Mahmoud H, Chesney RW (1995) Tumor lysis syndrome:<br />
Pathogenesis and management. Pediatr Nephrol 9(2):206–212<br />
4. Spector T (1977) Inhibition of urate production by allopurinol. Biochem<br />
Pharmacol 26(5):355–358<br />
5. Goldman SC, Holcenberg JS, Finklestein JZ, et al. (2001) A randomized<br />
comparison between rasburicase and allopurinol in children<br />
with lymphoma or leukemia at high risk for tumor lysis. Blood<br />
97(10):2998–3003<br />
6. Cairo MS, Bishop M (2004) Tumour lysis syndrome: New therapeutic<br />
strategies and classification. Br J Haematol 127(1):3–11<br />
7. Brogard JM, Coumaros D, Franckhauser J, Stahl A, Stahl J (1972)<br />
Enzymatic uricolysis: A study of the effect of a fungal urate-oxydase.<br />
Rev Eur Etud Clin Biol 17(9):890–895<br />
8. Yeldandi AV, Yeldandi V, Kumar S, et al. (1991) Molecular evolution<br />
of the urate oxidase-encoding gene in hominoid primates: Nonsense<br />
mutations. Gene 109(2):281–284<br />
9. Masera G, Jankovic M, Zurlo MG, et al. (1982) Urate-oxidase<br />
prophylaxis of uric acid-induced renal damage in childhood<br />
leukemia. J Pediatr 100(1):152–155<br />
10. Pui CH, Relling MV, Lascombes F, et al. (1997) Urate oxidase in prevention<br />
and treatment of hyperuricemia associated with lymphoid<br />
malignancies. Leukemia 11(11):1813–1816<br />
11. Patte C, Sakiroglu C, Ansoborlo S, et al. (2002) Urate-oxidase in the<br />
prevention and treatment of metabolic complications in patients<br />
with B-cell lymphoma and leukemia, treated in the Societe Fran-<br />
caise d‘Oncologie Pediatrique LMB89 protocol. Ann Oncol 13(5):<br />
789–795<br />
12. Legoux R, Delpech B, Dumont X, et al. (1992) Cloning and expression<br />
in Escherichia coli of the gene encoding Aspergillus flavus<br />
urate oxidase. J Biol Chem 267(12):8565–8570<br />
13. Coiffier B, Mounier N, Bologna S, et al. (2003) Efficacy and safety of<br />
rasburicase (recombinant urate oxidase) for the prevention and<br />
treatment of hyperuricemia during induction chemotherapy of<br />
aggressive non-Hodgkin‘s lymphoma: Results of the GRAAL1<br />
(Groupe d‘Etude des Lymphomes de l‘Adulte Trial on Rasburicase<br />
Activity in Adult Lymphoma) study. J Clin Oncol 21(23):4402–4406<br />
14. Lee AC, Li CH, So KT, Chan R (2003) Treatment of impending tumor<br />
lysis with single-dose rasburicase. Ann Pharmacother 37(11):<br />
1614–1617<br />
15. Trifilio S, Tallman M, Singhal S, Gordon L, Evens A, Mehta J (2004)<br />
Low-dose recombinant urate oxidase (rasburicase) is effective in<br />
hyperuricemia. 46th ASH Annual Meeting<br />
16. Jeha S (2001) Tumor lysis syndrome. Semin Hematol 38(4 Suppl<br />
10):4–8<br />
17. Kelly KM, Lange B (1997) Oncologic emergencies. Pediatr Clin<br />
North Am 44(4):809–830<br />
18. Sillos EM, Shenep JL, Burghen GA, Pui CH, Behm FG, Sandlund JT<br />
(2001) Lactic acidosis: A metabolic complication of hematologic<br />
malignancies: Case report and review of the literature. Cancer<br />
92(9):2237–2246<br />
19. Mazurek S, Boschek CB, Eigenbrodt E (1997) The role of phosphometabolites<br />
in cell proliferation, energy metabolism, and tumor<br />
therapy. J Bioenerg Biomembr 29(4):315–330<br />
20. Mathupala SP, Rempel A, Pedersen PL (1997) Aberrant glycolytic<br />
metabolism of cancer cells: A remarkable coordination of genetic,<br />
transcriptional, post-translational, and mutational events that<br />
lead to a critical role for type II hexokinase. J Bioenerg Biomembr<br />
29(4):339–343<br />
21. Elmlinger MW, Wimmer K, Biemer E, Blum WF, Ranke MB, Dannecker<br />
GE (1996) Insulin-like growth factor binding protein 2 is<br />
differentially expressed in leukaemic B- and T-cell lines. Growth<br />
Regul 6(3):152–157<br />
22. Cohick WS, Clemmons DR (1993) The insulin-like growth factors.<br />
Annu Rev Physiol 55:131–153<br />
23. Werner H, LeRoith D (1996) The role of the insulin-like growth factor<br />
system in human cancer. Adv Cancer Res 68:183–223<br />
24. Durig J, Fiedler W, de Wit M, Steffen M, Hossfeld DK (1996) Lactic<br />
acidosis and hypoglycemia in a patient with high-grade non-<br />
Hodgkin‘s lymphoma and elevated circulating TNF-alpha. Ann<br />
Hematol 72(2):97–99<br />
25. Tiefenthaler M, Amberger A, Bacher N, et al. (2001) Increased lactate<br />
production follows loss of mitochondrial membrane potential<br />
during apoptosis of human leukaemia cells. Br J Haematol<br />
114(3):574–580<br />
26. Sculier JP, Nicaise C, Klastersky J (1983) Lactic acidosis: A metabolic<br />
complication of extensive metastatic cancer. Eur J Cancer Clin Oncol<br />
19(5):597–601<br />
27. Stacpoole PW (1986) Lactic acidosis: The case against bicarbonate<br />
therapy. Ann Intern Med 105(2):276–279<br />
28. Cooper DJ, Walley KR, Wiggs BR, Russell JA (1990) Bicarbonate<br />
does not improve hemodynamics in critically ill patients who have<br />
lactic acidosis. A prospective, controlled clinical study. Ann Intern<br />
Med 112(7):492–498